Filter
1197
Text search:
human
pharmaceutical
products
Featured
113
332
Language
Document type
603
242
179
67
64
15
13
8
4
1
1
Countries / Regions
60
44
42
37
27
26
26
24
23
23
22
19
18
18
17
17
15
14
13
12
12
11
11
11
11
9
9
8
7
6
6
6
6
6
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
494
90
60
41
31
24
8
1
Toolboxes
157
129
72
57
49
47
41
39
25
22
21
20
19
16
14
9
7
6
5
5
3
1
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Prices people pay for medicines.
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in
...
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...
Health Systems in Transition. Vol. 5 No.3 2015
Psychatry & Pediatrics
Chapter I.3
